HLA-B and rheumatoid arthritis: Patients with SE and HLA-B*44 would probably benefit most from early and more aggressive therapy of RA, at least methotrexate, to reduce the production of proinflammatory cytokines and to prevent the development of autoimmune memory cells [36].